您当前所在的位置:首页 > 产品中心 > 产品详细信息
72822-12-9 分子结构
点击图片或这里关闭

1-(2-methylphenyl)-4-(2-{5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-3-yl}ethyl)piperazine

ChemBase编号:183
分子式:C19H27N5
平均质量:325.45118
单一同位素质量:325.22664589
SMILES和InChIs

SMILES:
N1(CCN(CC1)c1c(cccc1)C)CCc1n2CCCCc2nn1
Canonical SMILES:
Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2
InChI:
InChI=1S/C19H27N5/c1-16-6-2-3-7-17(16)23-14-12-22(13-15-23)11-9-19-21-20-18-8-4-5-10-24(18)19/h2-3,6-7H,4-5,8-15H2,1H3
InChIKey:
RFWZESUMWJKKRN-UHFFFAOYSA-N

引用这个纪录

CBID:183 http://www.chembase.cn/molecule-183.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
1-(2-methylphenyl)-4-(2-{5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-3-yl}ethyl)piperazine
IUPAC传统名
dapiprazole
商标名
Rev-Eyes
别名
Dapiprazole
CAS号
72822-12-9
PubChem SID
160963646
46508859
PubChem CID
3033538

数据来源

数据来源

所有数据来源 商品来源 非商品来源
数据来源 数据ID
DrugBank DB00298 external link
PubChem 3033538 external link
数据来源 数据ID 价格

理论计算性质

理论计算性质

JChem ALOGPS 2.1
质子受体 质子供体
LogD (pH = 5.5) 0.26387095  LogD (pH = 7.4) 1.9607973 
Log P 2.4158738  摩尔折射率 100.2216 cm3
极化性 37.01138 Å3 极化表面积 37.19 Å2
可自由旋转的化学键 里宾斯基五规则 true 
Log P 2.78  LOG S -2.64 
溶解度 7.51e-01 g/l 

分子性质

分子性质

理化性质 生物活性(PubChem)
溶解度
Soluble expand 查看数据来源
疏水性(logP)
2.3 expand 查看数据来源

详细说明

详细说明

DrugBank DrugBank
DrugBank -  DB00298 external link
Item Information
Drug Groups approved
Description Dapiprazole (U.S. trade name Rev-Eyes) is an alpha blocker. It is used to reverse mydriasis after eye examination. [Wikipedia]
Indication Used in the treatment of iatrogenically induced mydriasis produced by adrenergic (phenylephrine) or parasympatholytic (tropicamide) agents used in certain eye examinations.
Pharmacology Dapiprazole is an alpha-adrenergic blocking agent. It produces miosis by blocking the alpha-adrenergic receptors on the dilator muscle of the iris. Dapiprazole produces no significant action on ciliary muscle contraction and thus, there are no changes in the depth of the anterior chamber of the thickness of the lens. It does not alter the IOP either in normal eyes or in eyes with elevated IOP. The rate of pupillary constriction may be slightly slower in clients with brown irises than in clients with blue or green irises.
Toxicity Oral LD50 is 1189-2100 mg/kg in mice, rats and rabbits.
Affected Organisms
Humans and other mammals
Absorption Systemic absorption is negligible.
External Links
Wikipedia
Drugs.com

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    暂无数据
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle